Similar results were observed when the HLA A2+ NY‐ESO‐1+ tumour cell line MEL624.38 was used as a target, confirming that CD4+ T cells could be reprogrammed to recognize tumour cells directly by producing Th1‐type cytokines (Supporting information, Fig. S3). Here, CD4 is linked to neoplasm.